Inflammation, vitamin B6 and related pathways.

Area of Science:

• Biochemistry
• Immunology
• Nutritional Science

Background:

• The active form of vitamin B6, pyridoxal 5 '-phosphate (PLP), is crucial for over 150 enzymatic reactions.
• Plasma PLP levels are consistently reduced in inflammatory conditions, impacting various tissues and biomarkers.
• Low plasma PLP is associated with increased risk of cardiovascular disease and cancers, correlating inversely with inflammatory markers.

Purpose of the Study:

• To explore the role of vitamin B6 in inflammatory conditions.
• To investigate the potential mechanisms linking vitamin B6 status to immune function and chronic disease.
• To identify key vitamin B6-dependent pathways involved in inflammation.

Main Methods:

• Review of existing clinical and population-based studies on plasma PLP levels in inflammatory states.
• Analysis of associations between vitamin B6 status, inflammatory markers, and chronic disease risk.
• Examination of vitamin B6-dependent metabolic pathways relevant to immune modulation.

Main Results:

• Plasma PLP is consistently low in inflammation, with varying degrees of reduction in different tissues.
• Vitamin B6 intake and supplementation can enhance immune function in deficient individuals.
• Vitamin B6 may be mobilized to inflammatory sites, acting as a co-factor in immunomodulatory pathways.

Conclusions:

• Vitamin B6 status, particularly plasma PLP, is a significant indicator of inflammatory processes and chronic disease risk.
• Mobilization of vitamin B6 to inflamed tissues is a potential mechanism for its immunomodulatory effects.
• Understanding vitamin B6-dependent pathways like the kynurenine pathway is key to elucidating its role in inflammation and immunity.